Cargando…
Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
A large number of auto-immune diseases are treated with rituximab, an antibody against CD20 that depletes most of the B-cells in the organism. The response to this treatment depends largely on the disease and the type of lymphoid cells involved in the auto-immune process. We recently reported that B...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873528/ https://www.ncbi.nlm.nih.gov/pubmed/24409184 http://dx.doi.org/10.3389/fimmu.2013.00494 |